BioScrip Cash Flow - Quarterly (NASDAQ:BIOS)

Add to My Stocks
$3 $0.01 (0.33%) BIOS stock closing price Aug 17, 2017 (Closing)

The BioScrip cash flow statement is one of the three reports that the company generates every quarter. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For BioScrip profits one has to check the income statement and for BioScrip debt one has to check the balance sheet. BioScrip stock analysis shows negative net income cash flow of $-48.63M for 2017-Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required.   BioScrip had an inflow of $6M from operating activities, $21.11M inflow due to financing activities, and $2.54M spend due to investing activities for 2017-Q2. View details of BioScrip cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
BioScrip Net Income Cash Flow
-48.63M-19.42M-41.5M-29.03M-17.77M-9.53M-299.7M-281.26M-264.48M-19.67M
Depreciation Depletion Amortization Cash-Flow16.65M8.3M25.59M15.96M10.77M5.54M26.18M271.5M251.2M6.57M
Net Increase (Decrease) in Assets Liabilities10.55M-1.05M-11.43M-14.57M-9.88M-1.5M-21.28M-39.75M-21.72M-18.55M
Cash From (used in) Discontinued Operations---0.42M-6.22M-6.22M-6.22M-6.17M-1.11M1.3M-
Other Adjustments Net16.39M1.14M-14.99M-4.66M1.5M0.76M236.24M-16.79M-12.45M3.6M
BioScrip Net Cash from (used by) Operating Activities
-5.03M-11.03M-42.76M-38.53M-21.58M-10.96M-64.74M-67.41M-46.16M-28.04M
Increase (Decrease) in Prop Plant And Equipment-4.29M-1.68M-5.46M-3.86M-4.33M-1.32M-11.54M-9.35M-5.79M-2.06M
Acquisition Disposition of Subsidiaires---67.51M-67.51M------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities-5.06M-5.13M----24.56M22.37M--
BioScrip Net Cash from (used by) Invesment Activities
-9.35M-6.81M-72.98M-71.38M-4.33M-1.32M13.02M13.01M-5.79M-2.06M
Issuance (Purchase) of Equity Shares20.78M5.05M83.06M-83.26M-59.58M59.69M58.95M58.95M
Issuance (Repayment) of Debt Securities80.34M19.68M-13.62M-9.93M-6.4M-3.18M-0.39M-0.31M-0.34M-0.11M
Increase (Decrease) in Bank & Other Borrowings-55.3M-0.43M40.3M24M-15M8M10M25M-5M-5M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.47M-0.05M-83.11M-0.09M-0.05M-2.63M-1.27M-1.21M-1.21M
BioScrip Net Cash from (used by) Financing Activities
45.35M24.24M109.74M97.17M61.77M4.75M66.55M83.09M52.39M52.61M
Effect of Exchange Rate Changes on Cash----------
BioScrip Net Change in Cash & Cash Equivalents
30.96M6.4M-6M-12.74M35.84M-7.52M14.83M28.7M0.43M22.5M
Cash & Equivalents at Beginning of Year15.57M0.74M1M62.1M------
Cash & Equivalents at Year End40.53M15.96M9.56M2.83M51.42M8.05M15.57M29.44M1.17M23.24M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

1:29
BIOS
BioScrip stock comparison chart provides an easy way to compare the stock price with peers along with details of BioScrip stock price history.
The statement of cash flows can be categorized into three main sections:
  • BioScrip has cash of $40.53M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the BioScrip stock price.
  • BioScrip increased its cash from operating activities to $6M in 2017-Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-9.35M for BIOS stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $45.35M for BioScrip. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.
.

Key Financial Ratios For BioScrip Cash Flow

FCF margin
-0.06